DV
Dividend Vision

VIR — Vir Biotechnology Inc.

Vir Biotechnology Inc. (VIR)

Total return is -34.1% over the past 6.8 years, 223.0 points behind SPY at 188.9%. Its deepest 1-year drawdown was 25.6%.

VIR is an equity stock that operates in the biotechnology sector. As a single-stock holding rather than a diversified fund, it does not have a traditional dividend distribution rate or expense ratio associated with a fund structure. This ticker appeals primarily to growth-oriented investors seeking exposure to biotechnology innovation rather than to income-focused investors seeking regular dividend distributions.

VIR key facts

Asset type
Stock
Asset class
Equity
Inception date
10/11/2019
Distribution frequency
None
Last close
$9.24
Market cap
$1,563,555,328
Average volume
1016300.0
Beta
1.591
Payout ratio
0.0
Forward P/E
4.2717
EPS
$-1.77